FOXG1 Research Foundation Email Format
Research ServicesNew York, United States11-50 Employees
The FOXG1 Research Foundation (FRF) is a US-based nonprofit organization focused on accelerating research into FOXG1 syndrome, a severe developmental brain disorder. Founded in 2017 by affected families, FRF supports scientific work aimed at pursuing disease-modifying therapies and preparing for human clinical trials within a few years, with active collaboration among researchers, clinicians, and patient communities. Based in Port Washington, New York, the organization operates in the research services sector and has a mission centered on advancing understanding and treatment options for FOXG1 syndrome and related brain disorders. Recent activities include strategic program development and partnerships intended to move gene therapy and other therapeutic approaches toward clinical evaluation, reflecting FRF’s role as a patient-led driver within the broader rare disease and neuroscience landscape.